Fenazine Injection 25 mg/ml contains Fluphenazine Decanoate, a long-acting antipsychotic medication belonging to the phenothiazine class. It is formulated as a depot injection designed for intramuscular administration, providing sustained therapeutic effects over an extended period. Fenazine Injection is primarily used in the long-term management of chronic psychotic disorders, particularly schizophrenia, in patients who require continuous antipsychotic treatment and may have difficulty adhering to oral medication regimens.
The depot formulation ensures steady plasma drug levels, reducing symptom relapse associated with inconsistent dosing and improving overall treatment compliance. Fenazine Injection is intended for use under strict medical supervision by trained healthcare professionals.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Typical Antipsychotic / Phenothiazine Derivative
Fenazine Injection 25 mg/ml is indicated for:
Maintenance treatment of schizophrenia
Long-term management of chronic psychotic disorders
Patients requiring prolonged antipsychotic therapy where oral treatment adherence is inadequate
Each ml contains:
Fluphenazine Decanoate BP 25 mg
Fluphenazine Decanoate is a long-acting ester of fluphenazine, a potent dopamine D2 receptor antagonist. After intramuscular injection, the decanoate ester is slowly hydrolyzed to release active fluphenazine into the systemic circulation. By blocking dopamine receptors in the mesolimbic and mesocortical pathways, it helps control positive symptoms of psychosis such as hallucinations, delusions, and disorganized thinking. The depot formulation allows sustained antipsychotic activity for several weeks following a single injection.
Fenazine Injection exerts its antipsychotic effect by antagonizing dopamine D2 receptors in the brain. This action reduces excessive dopaminergic activity associated with psychotic symptoms. Its long-acting nature ensures stable drug levels, minimizing symptom fluctuations and reducing the risk of relapse.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Administered by deep intramuscular injection only
Initial and maintenance doses are individualized based on patient response and clinical condition
Common dosing interval ranges from every 2 to 4 weeks
Dose adjustment should be done gradually under medical supervision
Fenazine Injection may interact with:
Central nervous system depressants such as alcohol, sedatives, and opioids
Antihypertensive drugs, which may enhance hypotensive effects
Anticholinergic agents and other antipsychotics
Concomitant use should be monitored carefully by a healthcare professional.
Fenazine Injection is contraindicated in patients with:
Hypersensitivity to fluphenazine or other phenothiazines
Severe central nervous system depression
Comatose states
Bone marrow depression
Possible side effects include:
Extrapyramidal symptoms such as rigidity, tremor, and akathisia
Sedation and dizziness
Orthostatic hypotension
Dry mouth, constipation, and blurred vision
Injection site reactions
Long-term use may be associated with tardive dyskinesia.
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Fluphenazine may be excreted in breast milk; therefore, breastfeeding is not recommended during treatment.
Regular monitoring is advised for patients receiving long-term therapy. Caution should be exercised in elderly patients and those with cardiovascular disease, hepatic impairment, or seizure disorders.
Store below 30°C, protected from light. Keep out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet